Fact checked byMindy Valcarcel, MS

Read more

August 06, 2022
1 min read
Save

MD Anderson fellow receives ASH-CIBMTR-ASTCT career development award

Fact checked byMindy Valcarcel, MS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Owhofasa Agbedia, MD, MPH, received this year’s ASH-CIBMTR-ASTCT Career Development Award.

The award — part of program to increase racial and ethnic diversity in the next generation of medical professionals — is presented by ASH, Center for International Blood and Marrow Transplant Research (CIBMTR) and American Society for Transplantation and Cellular Therapy (ASTCT). CIBMTR is a research collaboration between National Marrow Donor Program (NMDP)/Be The Match and Medical College of Wisconsin.

The award includes a $100,000 stipend to conduct clinical or laboratory-based hematology research projects. The recipient also receives in-person mentoring from faculty at CIBMTR’s two parent institutions.

Owhofasa Agbedia, MD, MPH
Owhofasa Agbedia

Agbedia also will participate in ASTCT leadership and clinical research training courses, receive registration to next year’s Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, and be invited to present research during the Promoting Minorities in Hematology event at ASH Annual Meeting and Exposition.

Agbedia is a fellow in hematology/oncology at The University of Texas MD Anderson Cancer Center and a graduate student at MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. Agbedia is interested in investigating an innovative cellular therapeutic option for treating CD94-expressing natural killer/T-cell lymphoproliferative disorders.

“Along with our partner organizations, the CIBMTR is committed to supporting the career development of our next generation, particularly those with diverse backgrounds. In so doing, we ensure the future success of our field by fostering the minds and hearts of those who will discover novel approaches to improve patient outcomes,” Jeffery Auletta, MD, CIBMTR’s chief scientific director, said in a release.